Reduced gray matter volume in the brain may be able to explain the link between blood sugar fluctuations and depression risk, according to a new study.
The FDA has recently approved a cellular therapy for type 1 diabetes for the first 1. The therapy, called Lantidra, can reduce the need for insulin injections.
Type 2 diabetes patients exhibit brain tissue damage in mood and cognitive regions, impacting their functions. Diffusion tensor imaging reveals chronic tissue changes in various brain areas, such as the cerebellum and frontal cortex, correlating with mood and cognitive symptoms.